ETF Components for CANC - Tema Oncology ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
AMGN F -1.83 5.39
GILD B -0.56 5.14
REGN F -2.71 4.87
RVMD C -1.31 4.54
ILMN C -2.69 4.34
INCY B -3.42 4.16
ARGX B -0.72 3.99
BPMC C -1.27 3.66
EXEL B -0.40 2.87
MREO D -5.68 2.60
AGIO B -5.46 2.58
CRSP D -5.90 2.44
BGNE D -1.11 2.35
MRK F -0.14 2.27
DAWN D -3.57 2.00
NUVL D -0.18 1.99
NVS F -0.44 1.99
GMAB F -2.22 1.92
GH B -4.43 1.88
NTLA F -6.15 1.60
ACLX C -5.05 1.50
JANX C -1.71 1.45
EXAS F 0.39 1.45
MRUS C -2.49 1.43
CLDX F -4.10 1.42
LEGN F 1.37 1.38
SWTX C 5.30 1.36
LNTH F 1.35 1.28
SDGR C -7.79 1.07
COGT D -7.21 0.95
IDYA F -3.35 0.88
BCYC F -2.76 0.88
BNTX D -7.10 0.88
MRNA F -5.62 0.87
NRIX B -1.07 0.86
ORIC D -14.02 0.82
CGEM F -3.10 0.80
RLAY F -3.61 0.72
IMCR C -4.54 0.70
RCUS F -4.02 0.66
TERN F -3.39 0.62
CGON D 1.00 0.59
ARVN D -1.66 0.49

Recent News for Tema Oncology ETF & its Holdings

Date Stock Title
Nov 14 MRNA Vaccine makers close lower amid reports RFK Jr may head HHS (update)
Nov 14 BNTX Vaccine makers close lower amid reports RFK Jr may head HHS (update)
Nov 14 MRK Vaccine makers close lower amid reports RFK Jr may head HHS (update)
Nov 14 MRNA Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide.
Nov 14 MRNA Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official
Nov 14 AMGN AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024
Nov 14 BPMC Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst
Nov 14 AMGN Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate
Nov 14 GILD Gilead, Vertex initiated as new big biotech buys at Citi
Nov 14 AMGN 5 Healthcare Stocks to Buy in a Beaten-Up Sector
Nov 14 MRK Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial
Nov 14 AMGN Amgen's Options Frenzy: What You Need to Know
Nov 14 BNTX BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up
Nov 14 MRK Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics
Nov 14 ARGX (ARGX) - Analyzing argenx's Short Interest
Nov 14 AMGN 2 Dividend Stocks to Buy Hand Over Fist in November
Nov 14 CGEM Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024
Nov 14 AMGN Citi initiates coverage on 5 new biotech stocks
Nov 14 REGN Citi initiates coverage on 5 new biotech stocks
Nov 14 GILD Citi initiates coverage on 5 new biotech stocks
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Index Fund Private Equity Investment Management
Back to the Main CANC Page...